Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP568739.RASEpzUu8pC3Tr8Fj4gud1dDxq1B5zqe9uCH-dgG4--gM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP568739.RASEpzUu8pC3Tr8Fj4gud1dDxq1B5zqe9uCH-dgG4--gM130_assertion type Assertion NP568739.RASEpzUu8pC3Tr8Fj4gud1dDxq1B5zqe9uCH-dgG4--gM130_head.
- NP568739.RASEpzUu8pC3Tr8Fj4gud1dDxq1B5zqe9uCH-dgG4--gM130_assertion description "[Further investigations revealed that knock-down of AGO2 by custom-made AGO2 siRNA in HEK-293 cells resulted in silencing of the expression of target genes vascular endothelial growth factor A and histone deacetylase 2, which are known to be involved in the development of myeloid leukaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP568739.RASEpzUu8pC3Tr8Fj4gud1dDxq1B5zqe9uCH-dgG4--gM130_provenance.
- NP568739.RASEpzUu8pC3Tr8Fj4gud1dDxq1B5zqe9uCH-dgG4--gM130_assertion evidence source_evidence_literature NP568739.RASEpzUu8pC3Tr8Fj4gud1dDxq1B5zqe9uCH-dgG4--gM130_provenance.
- NP568739.RASEpzUu8pC3Tr8Fj4gud1dDxq1B5zqe9uCH-dgG4--gM130_assertion SIO_000772 21535412 NP568739.RASEpzUu8pC3Tr8Fj4gud1dDxq1B5zqe9uCH-dgG4--gM130_provenance.
- NP568739.RASEpzUu8pC3Tr8Fj4gud1dDxq1B5zqe9uCH-dgG4--gM130_assertion wasDerivedFrom befree-20140225 NP568739.RASEpzUu8pC3Tr8Fj4gud1dDxq1B5zqe9uCH-dgG4--gM130_provenance.
- NP568739.RASEpzUu8pC3Tr8Fj4gud1dDxq1B5zqe9uCH-dgG4--gM130_assertion wasGeneratedBy ECO_0000203 NP568739.RASEpzUu8pC3Tr8Fj4gud1dDxq1B5zqe9uCH-dgG4--gM130_provenance.